NGM BIOPHARMACEUTICALS INC (NGM)
US62921N1054 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 55.82M | 73.50M | 151.80M | 147.00M | 245.60M | |||
| Marketable Securities | 88.37M | 198.00M | 214.50M | 148.10M | 98.90M | |||
| Receivables | 58.00K | 7.60M | 4.90M | 6.40M | 5.20M | |||
| Other Current Assets | 12.20M | 9.80M | 8.10M | 6.80M | 5.50M | |||
| Total Current Assets | 156.44M | 288.90M | 379.30M | 308.40M | 355.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.03M | 10.60M | 14.10M | 14.50M | 19.50M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 5.39M | 8.00M | 9.00M | 6.10M | 5.70M | |||
| Total Non-Current Assets | 12.42M | 18.50M | 23.10M | 20.60M | 25.20M | |||
| TOTAL ASSETS | 168.87M | 307.40M | 402.40M | 329.00M | 380.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 17.10M | 39.00M | 38.30M | 29.90M | 23.00M | |||
| Accounts Payable | 2.98M | 8.50M | 5.20M | 9.70M | 9.00M | |||
| Other Current Liabilities | 0.00 | 400.00K | 17.80M | 3.00M | 7.70M | |||
| Total Current Liabilities | 20.08M | 47.80M | 61.40M | 42.60M | 39.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 149.00K | 0.00 | 5.40M | 6.40M | 10.00M | |||
| Total Non-Current Liabilities | 149.00K | 0.00 | 5.30M | 6.40M | 10.00M | |||
| TOTAL LIABILITIES | 20.23M | 47.80M | 66.70M | 49.00M | 49.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -724.01M | -581.60M | -419.00M | -298.60M | -196.10M | |||
| Additional Paid In Capital | 872.54M | 841.40M | 754.70M | 578.60M | 526.80M | |||
| Common Shares | 83.00K | 100.00K | 100.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | 18.00K | -300.00K | -100.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 82.91M | 81.90M | 78.00M | 70.60M | 67.00M | |||
| Tangible Book Value per Share | 1.79 | 3.17 | 4.30 | 3.97 | 4.94 | |||
| Total Shareholders' Equity | 148.64M | 259.60M | 335.60M | 280.00M | 330.70M | |||
| TOTAL LIABILITIES AND EQUITY | 168.87M | 307.40M | 402.40M | 329.00M | 380.40M | |||
| Statistics | ||||||||
| Current Ratio | 7.79 | 6.04 | 6.18 | 7.24 | 8.95 | |||
| Return On Assets (ROA) | -84.31% | -52.93% | -29.90% | -31.16% | -11.25% | |||
| Return On Equity (ROE) | -95.79% | -62.67% | -35.85% | -36.61% | -12.94% | |||
All data in USD